Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China flag China · Delayed Price · Currency is CNY
24.62
-0.87 (-3.41%)
Aug 26, 2026, 3:04 PM CST

SHE:002317 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
746.86985.41,3991,252927.671,016
Short-Term Investments
-221.38163.69389.1151.7540
Trading Asset Securities
444.03103.66305.99683.06340.68239.92
Cash & Short-Term Investments
1,1911,3101,8692,3241,4201,296
Cash Growth
-11.16%-29.89%-19.58%63.66%9.55%-20.49%
Accounts Receivable
967.691,222999.6978.31,204792.46
Other Receivables
7.7849.4855.8545.6229.4411.48
Receivables
975.471,2711,0551,0241,233803.94
Inventory
385.88365.3441.48520.39481.06452.2
Prepaid Expenses
-----0
Other Current Assets
468.8796.4996.7492.1100.4119.12
Total Current Assets
3,0213,0443,4633,9613,2352,672
Property, Plant & Equipment
768.47802.14687.36695.91636.82601.24
Long-Term Investments
140.29299.33516.23519.95727.09650.61
Goodwill
6.956.956.95208.63208.63208.63
Other Intangible Assets
477.08503.71327.11446.7260.4261.28
Long-Term Deferred Tax Assets
15.7820.5729.6942.4547.0346.89
Long-Term Deferred Charges
487.92435.2489.91564.31586.61401.03
Other Long-Term Assets
49.821833.4419.9774.1560.76
Total Assets
4,9675,1305,5536,4595,7754,902

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
103.82117.9693.193.78126.28106.7
Accrued Expenses
18.63165.76141.86163.32232.01164.43
Short-Term Debt
116.94318.52303.46621.49587.6190
Current Portion of Long-Term Debt
1.77--2.092212
Current Portion of Leases
-1.741.662.722.551.71
Current Income Taxes Payable
19.592.814.9212.4613.611.51
Current Unearned Revenue
218.0620.620.0825.9145.2418.85
Other Current Liabilities
142.8490.93638.3993.5479.0429
Total Current Liabilities
621.65718.321,2031,0151,108524.2
Long-Term Debt
---97286308
Long-Term Leases
5.076.040.31.34.025.27
Long-Term Unearned Revenue
190.61202.05161.94132.6755.5732.74
Long-Term Deferred Tax Liabilities
47.1841.2738.948.9570.2359.96
Other Long-Term Liabilities
11.8112.03138.76637.61434.68433.67
Total Liabilities
876.32979.711,5431,9331,9591,364

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
849.93849.93851.56853.35814.43814.46
Additional Paid-In Capital
1,8221,8161,7801,8071,3101,321
Retained Earnings
1,2841,3421,2371,7061,6041,444
Treasury Stock
---8.1-67.14-80.36-151.6
Comprehensive Income & Other
48.6949.5154.8657.3654.4547.52
Total Common Equity
4,0044,0583,9154,3563,7033,476
Minority Interest
86.9191.6895.34169.37113.7262.49
Shareholders' Equity
4,0914,1504,0104,5263,8163,538
Total Liabilities & Equity
4,9675,1305,5536,4595,7754,902

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
123.78326.3305.43724.6902.17516.98
Net Cash (Debt)
1,067984.141,5641,600517.93779.3
Net Cash Growth
16.45%-37.06%-2.24%208.85%-33.54%-14.76%
Net Cash Per Share
1.271.181.881.940.640.98
Filing Date Shares Outstanding
882.36849.93846.01847.8808.88797.43
Total Common Shares Outstanding
882.36849.93846.01847.8808.88797.43
Working Capital
2,3992,3252,2592,9452,1262,147
Book Value Per Share
4.544.774.635.144.584.36
Tangible Book Value
3,5203,5483,5813,7013,2343,006
Tangible Book Value Per Share
3.994.174.234.374.003.77
Buildings
-573.53561.69527.39506.28474.51
Machinery
-763.36734.13638.4600.95568.8
Construction In Progress
-151.3127.58123.5582.0356.47